Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:CEO |
gptkb:Ashish_Koshy
|
| gptkbp:collaboratedWith |
gptkb:Oxford_Nanopore_Technologies
gptkb:Sinopharm |
| gptkbp:country |
gptkb:United_Arab_Emirates
|
| gptkbp:focusArea |
gptkb:insurance
clinical research population genomics AI-driven healthcare solutions |
| gptkbp:foundedYear |
2019
|
| gptkbp:headquartersLocation |
gptkb:Abu_Dhabi
|
| https://www.w3.org/2000/01/rdf-schema#label |
G42 Healthcare
|
| gptkbp:industry |
gptkb:artificial_intelligence
gptkb:biotechnology healthcare |
| gptkbp:notableEvent |
conducted Phase III clinical trials for Sinopharm COVID-19 vaccine in UAE
|
| gptkbp:notableProject |
gptkb:UAE_COVID-19_testing_program
gptkb:UAE_Genome_Program |
| gptkbp:parentOrganization |
G42
|
| gptkbp:subsidiary |
G42
|
| gptkbp:website |
https://www.g42healthcare.ae/
|
| gptkbp:bfsParent |
gptkb:Expo_2020_Dubai,_UAE
|
| gptkbp:bfsLayer |
6
|